A Study to Assess the Pharmacokinetics of Certolizumab Pegol in Adults With Active Rheumatoid Arthritis
Clinical trial NCT04740814 · COMPLETED
Trial details
- NCT number
- NCT04740814
- Sponsor
- UCB Biopharma SRL
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-11
- Primary completion
- 2022-01-24
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.